301201 诚达药业
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额43,23434,01828,648192,07247,666
投资活动产生之现金流量净额(227,871)266,399(1,209,478)594,391(988,636)
筹资活动产生之现金流量净额(8,173)(53,870)(7,123)(29,009)1,525,679
汇率变动对现金及现金等价物的影响(1,651)7762,2058041,229
现金及现金等价物净增加/(减少)(194,461)247,324(1,185,748)758,259585,937
期初现金及现金等价物余额424,265176,9411,362,689604,43018,493
期末现金及现金等价物余额229,804424,265176,9411,362,689604,430